High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years
"Non-invasive, faster and less expensive than MRI" and "the eye is a window to the brain" are recent slogans promoting optical coherence tomography (OCT) as a new surrogate marker in multiple sclerosis (MS). Indeed, OCT allows for the first time a non-invasive visualization of ax...
Gespeichert in:
Veröffentlicht in: | PloS one 2011-05, Vol.6 (5), p.e19843-e19843 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e19843 |
---|---|
container_issue | 5 |
container_start_page | e19843 |
container_title | PloS one |
container_volume | 6 |
creator | Serbecic, Nermin Aboul-Enein, Fahmy Beutelspacher, Sven C Vass, Clemens Kristoferitsch, Wolfgang Lassmann, Hans Reitner, Andreas Schmidt-Erfurth, Ursula |
description | "Non-invasive, faster and less expensive than MRI" and "the eye is a window to the brain" are recent slogans promoting optical coherence tomography (OCT) as a new surrogate marker in multiple sclerosis (MS). Indeed, OCT allows for the first time a non-invasive visualization of axons of the central nervous system (CNS). Reduction of retina nerve fibre layer (RNFL) thickness was suggested to correlate with disease activity and duration. However, several issues are unclear: Do a few million axons, which build up both optic nerves, really resemble billions of CNS neurons? Does global CNS damage really result in global RNFL reduction? And if so, does global RNFL reduction really exist in all MS patients, and follow a slowly but steadily ongoing pattern? How can these (hypothesized) subtle global RNFL changes be reliably measured and separated from the rather gross RNFL changes caused by optic neuritis? Before generally being accepted, this interpretation needs further critical and objective validation.
We prospectively studied 37 MS patients with relapsing remitting (n = 27) and secondary progressive (n = 10) course on two occasions with a median interval of 22.4±0.5 months [range 19-27]. We used the high resolution spectral domain (SD-)OCT with the Spectralis 3.5 mm circle scan protocol with locked reference images and eye tracking mode. Patients with an attack of optic neuritis within 12 months prior to the onset of the study were excluded.
Although the disease was highly active over the observation period in more than half of the included relapsing remitting MS patients (19 patients/32 relapses) and the initial RNFL pattern showed a broad range, from normal to markedly reduced thickness, no significant changes between baseline and follow-up examinations could be detected.
These results show that caution is required when using OCT for monitoring disease activity and global axonal injury in MS. |
doi_str_mv | 10.1371/journal.pone.0019843 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1299027193</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A476891544</galeid><doaj_id>oai_doaj_org_article_4b2e5cf113b6442c899b43764512a137</doaj_id><sourcerecordid>A476891544</sourcerecordid><originalsourceid>FETCH-LOGICAL-c592t-da491fb8469d725268c48afd7b9ac69cf6b80b8e8a286dad9995c64333acd1033</originalsourceid><addsrcrecordid>eNptUstu1DAUjRCIlsIfILDEAljM4FccmwVSNTxaqVIXlLXlOE7GIydObafVfAD_jaeTVh1UeeHXOedeH5-ieIvgEpEKfdn4KQzKLUc_mCWESHBKnhXHSBC8YBiS54_WR8WrGDcQloQz9rI4woghlBnHxd8z261BMNG7KVk_gDganYJyoPG9sgPwY7I6b7Vfm2AGbUDyve-CGtdb8On398Xl6uozyMB-csmOzoConQk-2vgVpLUBrQ0xgdY752_BNIKYpmYL_I0JIN16sDUqxNfFi1a5aN7M80nx5-ePq9XZ4uLy1_nq9GKhS4HTolFUoLbmlImmwiVmXFOu2qaqhdJM6JbVHNbccIU5a1QjhCg1o4QQpRsECTkp3u91R-ejnB2MEmEhIK6yXRlxvkc0Xm3kGGyvwlZ6ZeXdgQ-dVCE74oykNTalbhEiNaMUay5ETUnFaImwyl-Utb7N1aa6N402w87YA9HDm8GuZedvJIGCZcks8HEWCP56MjHJ3kZtnFOD8VOUnPGKccJYRn74D_n042ZUp3L_dmh9Lqt3mvKUZiWByruqyydQeTSmtzqnrbX5_IBA9wSdvz0G0z48EUG5y-p9M3KXVTlnNdPePbbngXQfTvIPyJfnxQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1299027193</pqid></control><display><type>article</type><title>High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Serbecic, Nermin ; Aboul-Enein, Fahmy ; Beutelspacher, Sven C ; Vass, Clemens ; Kristoferitsch, Wolfgang ; Lassmann, Hans ; Reitner, Andreas ; Schmidt-Erfurth, Ursula</creator><creatorcontrib>Serbecic, Nermin ; Aboul-Enein, Fahmy ; Beutelspacher, Sven C ; Vass, Clemens ; Kristoferitsch, Wolfgang ; Lassmann, Hans ; Reitner, Andreas ; Schmidt-Erfurth, Ursula</creatorcontrib><description>"Non-invasive, faster and less expensive than MRI" and "the eye is a window to the brain" are recent slogans promoting optical coherence tomography (OCT) as a new surrogate marker in multiple sclerosis (MS). Indeed, OCT allows for the first time a non-invasive visualization of axons of the central nervous system (CNS). Reduction of retina nerve fibre layer (RNFL) thickness was suggested to correlate with disease activity and duration. However, several issues are unclear: Do a few million axons, which build up both optic nerves, really resemble billions of CNS neurons? Does global CNS damage really result in global RNFL reduction? And if so, does global RNFL reduction really exist in all MS patients, and follow a slowly but steadily ongoing pattern? How can these (hypothesized) subtle global RNFL changes be reliably measured and separated from the rather gross RNFL changes caused by optic neuritis? Before generally being accepted, this interpretation needs further critical and objective validation.
We prospectively studied 37 MS patients with relapsing remitting (n = 27) and secondary progressive (n = 10) course on two occasions with a median interval of 22.4±0.5 months [range 19-27]. We used the high resolution spectral domain (SD-)OCT with the Spectralis 3.5 mm circle scan protocol with locked reference images and eye tracking mode. Patients with an attack of optic neuritis within 12 months prior to the onset of the study were excluded.
Although the disease was highly active over the observation period in more than half of the included relapsing remitting MS patients (19 patients/32 relapses) and the initial RNFL pattern showed a broad range, from normal to markedly reduced thickness, no significant changes between baseline and follow-up examinations could be detected.
These results show that caution is required when using OCT for monitoring disease activity and global axonal injury in MS.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0019843</identifier><identifier>PMID: 21611198</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Aquaporins ; Axons ; Biology ; Brain ; Central nervous system ; Coherence ; Demography ; Epidemiology ; Eye ; Eye injuries ; Follow-Up Studies ; Glaucoma ; High resolution ; Humans ; Magnetic resonance imaging ; Medicine ; Middle Aged ; Multiple sclerosis ; Multiple Sclerosis - diagnosis ; Nerve Fibers - pathology ; Nerves ; Neuritis ; Neurology ; Optic neuritis ; Optical Coherence Tomography ; Optics ; Pathology ; Patients ; Reduction ; Retina ; Retina - pathology ; Spectra ; Thickness ; Tomography ; Tomography, Optical Coherence - methods ; Young Adult</subject><ispartof>PloS one, 2011-05, Vol.6 (5), p.e19843-e19843</ispartof><rights>COPYRIGHT 2011 Public Library of Science</rights><rights>2011 Serbecic et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Serbecic et al. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c592t-da491fb8469d725268c48afd7b9ac69cf6b80b8e8a286dad9995c64333acd1033</citedby><cites>FETCH-LOGICAL-c592t-da491fb8469d725268c48afd7b9ac69cf6b80b8e8a286dad9995c64333acd1033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096644/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096644/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21611198$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Serbecic, Nermin</creatorcontrib><creatorcontrib>Aboul-Enein, Fahmy</creatorcontrib><creatorcontrib>Beutelspacher, Sven C</creatorcontrib><creatorcontrib>Vass, Clemens</creatorcontrib><creatorcontrib>Kristoferitsch, Wolfgang</creatorcontrib><creatorcontrib>Lassmann, Hans</creatorcontrib><creatorcontrib>Reitner, Andreas</creatorcontrib><creatorcontrib>Schmidt-Erfurth, Ursula</creatorcontrib><title>High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>"Non-invasive, faster and less expensive than MRI" and "the eye is a window to the brain" are recent slogans promoting optical coherence tomography (OCT) as a new surrogate marker in multiple sclerosis (MS). Indeed, OCT allows for the first time a non-invasive visualization of axons of the central nervous system (CNS). Reduction of retina nerve fibre layer (RNFL) thickness was suggested to correlate with disease activity and duration. However, several issues are unclear: Do a few million axons, which build up both optic nerves, really resemble billions of CNS neurons? Does global CNS damage really result in global RNFL reduction? And if so, does global RNFL reduction really exist in all MS patients, and follow a slowly but steadily ongoing pattern? How can these (hypothesized) subtle global RNFL changes be reliably measured and separated from the rather gross RNFL changes caused by optic neuritis? Before generally being accepted, this interpretation needs further critical and objective validation.
We prospectively studied 37 MS patients with relapsing remitting (n = 27) and secondary progressive (n = 10) course on two occasions with a median interval of 22.4±0.5 months [range 19-27]. We used the high resolution spectral domain (SD-)OCT with the Spectralis 3.5 mm circle scan protocol with locked reference images and eye tracking mode. Patients with an attack of optic neuritis within 12 months prior to the onset of the study were excluded.
Although the disease was highly active over the observation period in more than half of the included relapsing remitting MS patients (19 patients/32 relapses) and the initial RNFL pattern showed a broad range, from normal to markedly reduced thickness, no significant changes between baseline and follow-up examinations could be detected.
These results show that caution is required when using OCT for monitoring disease activity and global axonal injury in MS.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aquaporins</subject><subject>Axons</subject><subject>Biology</subject><subject>Brain</subject><subject>Central nervous system</subject><subject>Coherence</subject><subject>Demography</subject><subject>Epidemiology</subject><subject>Eye</subject><subject>Eye injuries</subject><subject>Follow-Up Studies</subject><subject>Glaucoma</subject><subject>High resolution</subject><subject>Humans</subject><subject>Magnetic resonance imaging</subject><subject>Medicine</subject><subject>Middle Aged</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - diagnosis</subject><subject>Nerve Fibers - pathology</subject><subject>Nerves</subject><subject>Neuritis</subject><subject>Neurology</subject><subject>Optic neuritis</subject><subject>Optical Coherence Tomography</subject><subject>Optics</subject><subject>Pathology</subject><subject>Patients</subject><subject>Reduction</subject><subject>Retina</subject><subject>Retina - pathology</subject><subject>Spectra</subject><subject>Thickness</subject><subject>Tomography</subject><subject>Tomography, Optical Coherence - methods</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptUstu1DAUjRCIlsIfILDEAljM4FccmwVSNTxaqVIXlLXlOE7GIydObafVfAD_jaeTVh1UeeHXOedeH5-ieIvgEpEKfdn4KQzKLUc_mCWESHBKnhXHSBC8YBiS54_WR8WrGDcQloQz9rI4woghlBnHxd8z261BMNG7KVk_gDganYJyoPG9sgPwY7I6b7Vfm2AGbUDyve-CGtdb8On398Xl6uozyMB-csmOzoConQk-2vgVpLUBrQ0xgdY752_BNIKYpmYL_I0JIN16sDUqxNfFi1a5aN7M80nx5-ePq9XZ4uLy1_nq9GKhS4HTolFUoLbmlImmwiVmXFOu2qaqhdJM6JbVHNbccIU5a1QjhCg1o4QQpRsECTkp3u91R-ejnB2MEmEhIK6yXRlxvkc0Xm3kGGyvwlZ6ZeXdgQ-dVCE74oykNTalbhEiNaMUay5ETUnFaImwyl-Utb7N1aa6N402w87YA9HDm8GuZedvJIGCZcks8HEWCP56MjHJ3kZtnFOD8VOUnPGKccJYRn74D_n042ZUp3L_dmh9Lqt3mvKUZiWByruqyydQeTSmtzqnrbX5_IBA9wSdvz0G0z48EUG5y-p9M3KXVTlnNdPePbbngXQfTvIPyJfnxQ</recordid><startdate>20110517</startdate><enddate>20110517</enddate><creator>Serbecic, Nermin</creator><creator>Aboul-Enein, Fahmy</creator><creator>Beutelspacher, Sven C</creator><creator>Vass, Clemens</creator><creator>Kristoferitsch, Wolfgang</creator><creator>Lassmann, Hans</creator><creator>Reitner, Andreas</creator><creator>Schmidt-Erfurth, Ursula</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110517</creationdate><title>High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years</title><author>Serbecic, Nermin ; Aboul-Enein, Fahmy ; Beutelspacher, Sven C ; Vass, Clemens ; Kristoferitsch, Wolfgang ; Lassmann, Hans ; Reitner, Andreas ; Schmidt-Erfurth, Ursula</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c592t-da491fb8469d725268c48afd7b9ac69cf6b80b8e8a286dad9995c64333acd1033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aquaporins</topic><topic>Axons</topic><topic>Biology</topic><topic>Brain</topic><topic>Central nervous system</topic><topic>Coherence</topic><topic>Demography</topic><topic>Epidemiology</topic><topic>Eye</topic><topic>Eye injuries</topic><topic>Follow-Up Studies</topic><topic>Glaucoma</topic><topic>High resolution</topic><topic>Humans</topic><topic>Magnetic resonance imaging</topic><topic>Medicine</topic><topic>Middle Aged</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - diagnosis</topic><topic>Nerve Fibers - pathology</topic><topic>Nerves</topic><topic>Neuritis</topic><topic>Neurology</topic><topic>Optic neuritis</topic><topic>Optical Coherence Tomography</topic><topic>Optics</topic><topic>Pathology</topic><topic>Patients</topic><topic>Reduction</topic><topic>Retina</topic><topic>Retina - pathology</topic><topic>Spectra</topic><topic>Thickness</topic><topic>Tomography</topic><topic>Tomography, Optical Coherence - methods</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Serbecic, Nermin</creatorcontrib><creatorcontrib>Aboul-Enein, Fahmy</creatorcontrib><creatorcontrib>Beutelspacher, Sven C</creatorcontrib><creatorcontrib>Vass, Clemens</creatorcontrib><creatorcontrib>Kristoferitsch, Wolfgang</creatorcontrib><creatorcontrib>Lassmann, Hans</creatorcontrib><creatorcontrib>Reitner, Andreas</creatorcontrib><creatorcontrib>Schmidt-Erfurth, Ursula</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Serbecic, Nermin</au><au>Aboul-Enein, Fahmy</au><au>Beutelspacher, Sven C</au><au>Vass, Clemens</au><au>Kristoferitsch, Wolfgang</au><au>Lassmann, Hans</au><au>Reitner, Andreas</au><au>Schmidt-Erfurth, Ursula</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2011-05-17</date><risdate>2011</risdate><volume>6</volume><issue>5</issue><spage>e19843</spage><epage>e19843</epage><pages>e19843-e19843</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>"Non-invasive, faster and less expensive than MRI" and "the eye is a window to the brain" are recent slogans promoting optical coherence tomography (OCT) as a new surrogate marker in multiple sclerosis (MS). Indeed, OCT allows for the first time a non-invasive visualization of axons of the central nervous system (CNS). Reduction of retina nerve fibre layer (RNFL) thickness was suggested to correlate with disease activity and duration. However, several issues are unclear: Do a few million axons, which build up both optic nerves, really resemble billions of CNS neurons? Does global CNS damage really result in global RNFL reduction? And if so, does global RNFL reduction really exist in all MS patients, and follow a slowly but steadily ongoing pattern? How can these (hypothesized) subtle global RNFL changes be reliably measured and separated from the rather gross RNFL changes caused by optic neuritis? Before generally being accepted, this interpretation needs further critical and objective validation.
We prospectively studied 37 MS patients with relapsing remitting (n = 27) and secondary progressive (n = 10) course on two occasions with a median interval of 22.4±0.5 months [range 19-27]. We used the high resolution spectral domain (SD-)OCT with the Spectralis 3.5 mm circle scan protocol with locked reference images and eye tracking mode. Patients with an attack of optic neuritis within 12 months prior to the onset of the study were excluded.
Although the disease was highly active over the observation period in more than half of the included relapsing remitting MS patients (19 patients/32 relapses) and the initial RNFL pattern showed a broad range, from normal to markedly reduced thickness, no significant changes between baseline and follow-up examinations could be detected.
These results show that caution is required when using OCT for monitoring disease activity and global axonal injury in MS.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>21611198</pmid><doi>10.1371/journal.pone.0019843</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2011-05, Vol.6 (5), p.e19843-e19843 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1299027193 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Adolescent Adult Aquaporins Axons Biology Brain Central nervous system Coherence Demography Epidemiology Eye Eye injuries Follow-Up Studies Glaucoma High resolution Humans Magnetic resonance imaging Medicine Middle Aged Multiple sclerosis Multiple Sclerosis - diagnosis Nerve Fibers - pathology Nerves Neuritis Neurology Optic neuritis Optical Coherence Tomography Optics Pathology Patients Reduction Retina Retina - pathology Spectra Thickness Tomography Tomography, Optical Coherence - methods Young Adult |
title | High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T13%3A41%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20resolution%20spectral%20domain%20optical%20coherence%20tomography%20(SD-OCT)%20in%20multiple%20sclerosis:%20the%20first%20follow%20up%20study%20over%20two%20years&rft.jtitle=PloS%20one&rft.au=Serbecic,%20Nermin&rft.date=2011-05-17&rft.volume=6&rft.issue=5&rft.spage=e19843&rft.epage=e19843&rft.pages=e19843-e19843&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0019843&rft_dat=%3Cgale_plos_%3EA476891544%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1299027193&rft_id=info:pmid/21611198&rft_galeid=A476891544&rft_doaj_id=oai_doaj_org_article_4b2e5cf113b6442c899b43764512a137&rfr_iscdi=true |